MARKEL GROUP (MKL)
(Delayed Data from NYSE)
$1,562.37 USD
-10.35 (-0.66%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $1,561.21 -1.16 (-0.07%) 5:20 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1,562.37 USD
-10.35 (-0.66%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $1,561.21 -1.16 (-0.07%) 5:20 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
Zacks News
MetLife (MET) Q2 Earnings Fall Shy of Estimates, Tumble Y/Y
by Zacks Equity Research
MetLife's (MET) second-quarter earnings results reflect muted revenues.
Prudential (PRU) Q2 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
Prudential (PRU) Q2 reflects higher policy charges and fee income offset by lower contributions from most of its segments.
CNO Financial's (CNO) Q2 Earnings Beat Estimates, Fall Y/Y
by Zacks Equity Research
CNO Financial's (CNO) second-quarter 2020 results reflect higher revenues and lower expenses, partly offset by reduced annuity collected premiums.
Markel (MKL) Q2 Earnings Rise Y/Y, Revenues Beat Estimates
by Zacks Equity Research
Markel's (MKL) second-quarter results reflect strong performance of Insurance and Reinsurance Segments, and solid underwriting results.
Markel (MKL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Markel (MKL) delivered earnings and revenue surprises of 57.01% and 2.49%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Markel (MKL) Q2 Earnings Expected to Decline
by Zacks Equity Research
Markel (MKL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Markel (MKL) Up 3% Since Last Earnings Report?
by Zacks Equity Research
Markel (MKL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Markel (MKL) Q1 Earnings Decline Y/Y, Revenues Lag Estimates
by Zacks Equity Research
Markel (MKL) Q1 results reflect weak performance of Insurance and Reinsurance Segments as well as higher operating expenses.
Progressive (PGR) to Report Q1 Earnings: Is a Beat in Store?
by Zacks Equity Research
Progressive's (PGR) first-quarter 2020 premiums are likely to have benefited from solid policies in force, higher retention, increased investment income and compelling product portfolio.
Cincinnati Financial Rides on Strong Segmental Performance
by Zacks Equity Research
Cincinnati Financial (CINF) holds potential to reap benefits driven by better pricing decisions and sound liquidity position.
Here's Why Investors Should Buy W.R. Berkley (WRB) Stock
by Zacks Equity Research
Riding high on a solid capital position and emerging international markets, W.R. Berkley (WRB) is well poised for growth.
Life Insurers Face Rating Downgrades Due to Coronavirus Fears
by Sapna Bagaria
Risks pertaining to equity, interest, mortality induced by the current economic downturn due to the coronavirus uncertainty compel rating agencies to alter their outlook for the insurance industry.
Markel Inks a Deal to Invest in Combined Lansing & Harvey
by Zacks Equity Research
Markel (MKL) agrees to the acquisition of majority stake in Lansing Building Products.
Markel Rides on Strong Net Premiums & Solid Capital Position
by Zacks Equity Research
Markel (MKL) is poised to benefit from improved net written premiums and initiatives undertaken.
First American Financial (FAF) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
First American Financial (FAF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Is Markel (MKL) Up 1.1% Since Last Earnings Report?
by Zacks Equity Research
Markel (MKL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insurers to Bet on Even as Coronavirus Induces Interest Cut
by Sapna Bagaria
Despite a rate cut in the central bank's funds, some property and casualty stocks with strong premium growth and solid capital position seem a lucrative investment option.
Here's Why Investors Should Retain Unum Group (UNM) Stock Now
by Zacks Equity Research
Unum Group (UNM) remains poised for growth on efficient operational results, strong segmental performance and solid liquidity position.
Here's Why Investors Should Buy Cincinnati Financial Stock
by Zacks Equity Research
Cincinnati Financial (CINF) remains poised for growth on efficient pricing decisions, strong performance of the Commercial Lines Insurance segment and appointment of new agencies.
First American (FAF) Signs Agreement to Acquire Docutech
by Zacks Equity Research
The buyout is expected to aid First American (FAF) in enhancing the real estate settlement process for customers.
Markel (MKL) Q4 Earnings and Revenues Miss Estimates, Up Y/Y
by Sapna Bagaria
Markel (MKL) Q4 results reflect strong contribution from insurance and Markel Ventures.
Markel (MKL) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Markel (MKL) delivered earnings and revenue surprises of -7.07% and -0.79%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Markel (MKL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Markel (MKL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold Selective Insurance (SIGI) Stock
by Zacks Equity Research
Selective Insurance (SIGI) remains poised for growth on geographic expansion, higher investment income and prudent capital deployment offset by higher expenses and cat loss.
Here's Why W.R. Berkley (WRB) Stock is an Attractive Bet
by Zacks Equity Research
W.R. Berkley (WRB) remains poised for growth on solid capital position and emerging international markets.